<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39128056</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2979-9139</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Thoracic research and practice</Title><ISOAbbreviation>Thorac Res Pract</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study.</ArticleTitle><Pagination><StartPage>162</StartPage><EndPage>167</EndPage><MedlinePgn>162-167</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5152/ThoracResPract.2024.23117.</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">&#xa0;Coronavirus disease 2019 (COVID-19) caused morbidity and mortality worldwide. Besides the acute effects, subacute and long-term effects are defined as long-COVID causing morbidity. The intensive care unit (ICU) data of long-COVID-19 cases were evaluated with the participation of 11 centers.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">&#xa0;Study was designed by Turkish Thoracic Society Respiratory Failure and Intensive Care Working Group to evaluate long COVID-19 patients. All patients followed up in the ICU with long-COVID diagnosis were included in point prevelance study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">&#xa0;A total of 41 long COVID-19 patients from 11 centers were included in the study. Half of the patients were male, mean age was 66 &#xb1; 14, body mass index was 27 &#xb1; 5. Hypertension, diabetes mellitus, lung cancer, malignancy, and heart failure rates were 27%, 51%, 34%, 34%, and 27%, respectively. Eighty percent had received COVID vaccine. Patients had moderate hypoxemic respiratory failure. APACHE II, SOFA score was 18 (14-26), 6 (3-8), respectively. Forty-six percent received invasive mechanical ventilator support, 42% were sepsis, 17% were septic shock. Bilateral (67%), interstitial involvement (37%) were most common in chest x-ray. Fibrosis (27%) was detected in thorax tomography. Seventy-one percent of patients received antibiotherapy (42% carbapenem, 22% linezolid). Sixty-one percent of the patients received corticosteroid treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">&#xa0;More than half of the patients had pneumonia and the majority of them used broad-spectrum antibiotics. Presence of comorbidities and malignancies, intensive care severity scores, intubation, and sepsis rates were high. Receiving corticosteroid treatment and extensive bilateral radiologic involvement due to COVID-19 might be the reasons for the high re-admission rate for the ICUs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tun&#xe7;ay</LastName><ForeName>Eylem</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, University of Medical Sciences &#x15e;ehit Prof. Dr. &#x130;lhan Varank Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo&#xe7;in</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University S&#xfc;reyyapa&#x15f;a Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edibo&#x11f;du</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Dr. Suat Seren Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ad&#x131;g&#xfc;zel</LastName><ForeName>Nalan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University S&#xfc;reyyapa&#x15f;a Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ng&#xf6;r</LastName><ForeName>Sinem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University S&#xfc;reyyapa&#x15f;a Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;&#x15f;canl&#x131;</LastName><ForeName>&#x130;n&#x15f;a</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Sultan Abd&#xfc;lhamid Han Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Er</LastName><ForeName>Berrin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendil</LastName><ForeName>Nilgin Alptekino&#x11f;lu</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, TC Ministry of Health, Mersin City Hospital, Mersin, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usalan</LastName><ForeName>Adnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Tarsus Medikalpark Hospital, Mersin, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;lmaz</LastName><ForeName>Didem</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Tarsus Medikalpark Hospital, Mersin, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keskin</LastName><ForeName>H&#xfc;lya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Kartal Dr. L&#xfc;tfi K&#x131;rdar City Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf6;nmez</LastName><ForeName>G&#xfc;l Erdal</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University S&#xfc;reyyapa&#x15f;a Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;lmaz</LastName><ForeName>Bar&#x131;&#x15f;</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University S&#xfc;reyyapa&#x15f;a Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karg&#x131;n</LastName><ForeName>Feyza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Kartal Dr. L&#xfc;tfi K&#x131;rdar City Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sara&#xe7;o&#x11f;lu</LastName><ForeName>Kemal Tolga</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Kartal Dr. L&#xfc;tfi K&#x131;rdar City Hospital, &#x130;stanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temel</LastName><ForeName>&#x15e;ahin</ForeName><Initials>&#x15e;</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erciyes University Faculty of Medicine, Kayseri, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal</LastName><ForeName>Hayriye Cankar</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>Sema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, TC Ministry of Health, Ankara City Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talan</LastName><ForeName>Leyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho&#x15f;g&#xfc;n</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Ankara Atat&#xfc;rk Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydemir</LastName><ForeName>Semih</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Health Sciences University Ankara Atat&#xfc;rk Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sungurtekin</LastName><ForeName>H&#xfc;lya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Pamukkale University Faculty of Medicine, Denizli, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Thorac Res Pract</MedlineTA><NlmUniqueID>9918609982606676</NlmUniqueID><ISSNLinking>2979-9139</ISSNLinking></MedlineJournalInfo><CoiStatement><b>Declaration of Interests:</b> The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>11</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39128056</ArticleId><ArticleId IdType="pmc">PMC11363373</ArticleId><ArticleId IdType="doi">10.5152/ThoracResPract.2024.23117.</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tirelli U, Taibi R, Chirumbolo S. Post COVID syndrome: a new challenge for medicine. Eur Rev Med Pharmacol Sci. 2021;25(12):4422 4425. (10.26355/eurrev_202106_26154)</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202106_26154</ArticleId><ArticleId IdType="pubmed">34227079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: what do we know about &#x201c;long covid&#x201d;? BMJ. 2020;370:m2815. (10.1136/bmj.m2815)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A,et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601 615. (10.1038/s41591-021-01283-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late complications of COVID-19; a systematic review of current evidence. Arch Acad Emerg Med. 2021;9(1):e14. (10.22037/aaem.v9i1.1058)</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v9i1.1058</ArticleId><ArticleId IdType="pmc">PMC7927752</ArticleId><ArticleId IdType="pubmed">33681819</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113 119. (10.1007/s00408-021-00423-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737 754. (10.1080/23744235.2021.1924397)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Harenwall S, Heywood-Everett S, Henderson R, et al. Post-Covid-19 syndrome: improvements in health-related quality of life following psychology-led interdisciplinary virtual rehabilitation. J Prim Care Community Health. 2021;12:21501319211067674. (10.1177/21501319211067674)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319211067674</ArticleId><ArticleId IdType="pmc">PMC8721676</ArticleId><ArticleId IdType="pubmed">34939506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitoria P&#xe9;rez N, Puentes Guti&#xe9;rrez AB, S&#xe1;nchez Casado M, D&#xed;az Jim&#xe9;nez M, Garc&#xed;a Bascones M, Puentes Guti&#xe9;rrez R. S&#xed;ndrome pos-COVID tras ingreso en UCI. Par&#xe1;metros relacionados con una mejor recuperaci&#xf3;n f&#xed;sica a los 4 meses. Rev Esp Salud Publica. 2022;96:e202203025.</Citation><ArticleIdList><ArticleId IdType="pubmed">35232954</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute Covid-19 in primary care. BMJ. 2020;370:m3026. (10.1136/bmj.m3026)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220 232. (10.1016/S0140-6736(20)32656-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27(1):154 159. (10.1007/s13365-021-00949-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00949-1</ArticleId><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626 631. (10.1038/s41591-021-01292-y)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands: A longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73(11):e4058 e4063. (10.1093/cid/ciaa1792)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405 407. (10.1136/thoraxjnl-2020-216377)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919 1926. (10.1016/S0140-6736(20)31173-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31173-9</ArticleId><ArticleId IdType="pmc">PMC7255715</ArticleId><ArticleId IdType="pubmed">32473682</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60 73. (10.1007/s00134-020-06294-x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06294-x</ArticleId><ArticleId IdType="pmc">PMC7674575</ArticleId><ArticleId IdType="pubmed">33211135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Basti&#xe1;n M, Falces-Romero I, Ramos-Ramos JC, de Pablos M, Garc&#xed;a-Rodr&#xed;guez J, SARS-CoV-2 Working Group. Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: surfing the first wave. Diagn Microbiol Infect Dis. 2021;101(3):115477. (10.1016/j.diagmicrobio.2021.115477)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115477</ArticleId><ArticleId IdType="pmc">PMC8254382</ArticleId><ArticleId IdType="pubmed">34358876</ArticleId></ArticleIdList></Reference><Reference><Citation>Aul DR, Gates DJ, Draper DA, et al. Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis. Respir Med. 2021;188:106602. (10.1016/j.rmed.2021.106602)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106602</ArticleId><ArticleId IdType="pmc">PMC8425673</ArticleId><ArticleId IdType="pubmed">34536697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali RM, Ghonimy MB. Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egypt J Radiol Nucl Med. 2021;52(1):1 8.</Citation></Reference><Reference><Citation>Hu ZJ, Xu J, Yin JM, et al. Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients. Front Immunol. 2020;11:585647. (10.3389/fimmu.2020.585647)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.585647</ArticleId><ArticleId IdType="pmc">PMC7550399</ArticleId><ArticleId IdType="pubmed">33133104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama Amin BJ, Kakamad FH, Ahmed GS, et al. Post COVID-19 pulmonary fibrosis; a meta-analysis study. Ann Med Surg (Lond). 2022;77:103590. (10.1016/j.amsu.2022.103590)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103590</ArticleId><ArticleId IdType="pmc">PMC8983072</ArticleId><ArticleId IdType="pubmed">35411216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalmedicine. 2020;25:100463. (10.1016/j.eclinm.2020.100463)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>